Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 How further suppression of virus replication could improve current HBV treatment.

Literature DB >> 23977931

How further suppression of virus replication could improve current HBV treatment.

John E Tavis, Adam J Gehring, Yuan Hu.

Abstract

Entities: Chemical Disease Species

Mesh：

Year: 2013 PMID： 23977931 PMCID： PMC4436969 DOI： 10.1586/14787210.2013.814846

Source DB: PubMed Journal: Expert Rev Anti Infect Ther ISSN： 1478-7210 Impact factor: 5.091

× No keyword cloud information.

19 in total

Review 1. Hepatitis B virus infection--natural history and clinical consequences.

Authors: Don Ganem; Alfred M Prince
Journal: N Engl J Med Date: 2004-03-11 Impact factor: 91.245

2. Identification of disubstituted sulfonamide compounds as specific inhibitors of hepatitis B virus covalently closed circular DNA formation.

Authors: Dawei Cai; Courtney Mills; Wenquan Yu; Ran Yan; Carol E Aldrich; Jeffry R Saputelli; William S Mason; Xiaodong Xu; Ju-Tao Guo; Timothy M Block; Andrea Cuconati; Haitao Guo
Journal: Antimicrob Agents Chemother Date: 2012-05-29 Impact factor: 5.191

Review 3. Hepatitis B therapy.

Authors: Hellan Kwon; Anna S Lok
Journal: Nat Rev Gastroenterol Hepatol Date: 2011-03-22 Impact factor: 46.802

4. Molecular characterization of intrahepatic and extrahepatic hepatitis B virus (HBV) reservoirs in patients on suppressive antiviral therapy.

Authors: C S Coffin; P M Mulrooney-Cousins; M G Peters; G van Marle; J P Roberts; T I Michalak; N A Terrault
Journal: J Viral Hepat Date: 2011-06 Impact factor: 3.728

Review 5. Hepatitis B virus reactivation associated with anti-neoplastic therapy.

Authors: Winnie Yeo; Henry L Y Chan
Journal: J Gastroenterol Hepatol Date: 2013-01 Impact factor: 4.029

6. DNA prime-adenovirus boost immunization induces a vigorous and multifunctional T-cell response against hepadnaviral proteins in the mouse and woodchuck model.

Authors: Anna D Kosinska; Lena Johrden; Ejuan Zhang; Melanie Fiedler; Anja Mayer; Oliver Wildner; Mengji Lu; Michael Roggendorf
Journal: J Virol Date: 2012-06-20 Impact factor: 5.103

7. Kinetics of hepatitis B surface antigen decline during 3 years of telbivudine treatment in hepatitis B e antigen-positive patients.

Authors: Karsten Wursthorn; Mechthild Jung; Antonio Riva; Zachary D Goodman; Patricia Lopez; Weibin Bao; Michael P Manns; Heiner Wedemeyer; Nikolai V Naoumov
Journal: Hepatology Date: 2010-11 Impact factor: 17.425

8. Hepatitis B virus as a gene delivery vector activating foreign antigenic T cell response that abrogates viral expression in mouse models.

Authors: Qiang Deng; Maryline Mancini-Bourgine; Xiaoming Zhang; Marie-Christine Cumont; Ren Zhu; Yu-Chun Lone; Marie-Louise Michel
Journal: Hepatology Date: 2009-11 Impact factor: 17.425

Review 9. Hepatitis B virus resistance to nucleos(t)ide analogues.

Authors: Fabien Zoulim; Stephen Locarnini
Journal: Gastroenterology Date: 2009-09-06 Impact factor: 22.682

10. Chronic hepatitis B: what should be the goal for new therapies?

Authors: Timothy M Block; Robert Gish; Haitao Guo; Anand Mehta; Andrea Cuconati; W Thomas London; Ju-Tao Guo
Journal: Antiviral Res Date: 2013-02-04 Impact factor: 5.970

7 in total

1. Hepatitis B virus replication is blocked by a 2-hydroxyisoquinoline-1,3(2H,4H)-dione (HID) inhibitor of the viral ribonuclease H activity.

Authors: Catherine W Cai; Elena Lomonosova; Eileen A Moran; Xiaohong Cheng; Kunjan B Patel; Fabrice Bailly; Philippe Cotelle; Marvin J Meyers; John E Tavis
Journal: Antiviral Res Date: 2014-05-20 Impact factor: 5.970

2. Purification and enzymatic characterization of the hepatitis B virus ribonuclease H, a new target for antiviral inhibitors.

Authors: Juan Antonio Villa; Daniel P Pike; Kunjan B Patel; Elena Lomonosova; Gaofeng Lu; Roz Abdulqader; John E Tavis
Journal: Antiviral Res Date: 2016-06-17 Impact factor: 5.970

3. Efficacy of hepatitis B virus ribonuclease H inhibitors, a new class of replication antagonists, in FRG human liver chimeric mice.

Authors: Kelly R Long; Elena Lomonosova; Qilan Li; Nathan L Ponzar; Juan A Villa; Erin Touchette; Stephen Rapp; R Matt Liley; Ryan P Murelli; Alexandre Grigoryan; R Mark Buller; Lisa Wilson; John Bial; John E Sagartz; John E Tavis
Journal: Antiviral Res Date: 2017-11-10 Impact factor: 5.970

4. Hydroxylated tropolones inhibit hepatitis B virus replication by blocking viral ribonuclease H activity.

Authors: Gaofeng Lu; Elena Lomonosova; Xiaohong Cheng; Eileen A Moran; Marvin J Meyers; Stuart F J Le Grice; Craig J Thomas; Jian-kang Jiang; Christine Meck; Danielle R Hirsch; Michael P D'Erasmo; Duygu M Suyabatmaz; Ryan P Murelli; John E Tavis
Journal: Antimicrob Agents Chemother Date: 2014-12-01 Impact factor: 5.191